European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE

Biomarker Applications for Nanotechnology and Imaging in Diabetes


UroSense is a focussed research programme to generate new concepts from knowledge creation to knowledge transfer between innovative academic and dedicated industry partners utilising a systematic intersectoral secondment programme. The programme brings leading edge academic European LifeScience capacities of Diabetes research at Dublin City University, Ireland, together with the high-profile protein research center of University of Luxembourg to establish innovative biomarker utilisation. The nano-biotechnologies developed with established life science applications of Tethis S.p.A of Milano, Italy will be the SME partner to translate findings to microfluidic applications while GE Medical System of Sweden will integrate results to the recently established, robust molecular imaging technologies leading to novel diagnostics for the benefit of the diabetes patient. The Chinese partner is a leading biotech company in Guangzhou who will provide not only validation of results but also to develop access to the fastest growing global healthcare market benefiting both academic and industrial partners. All European partners are unequivocally in the leading edge in their own sectors sharing the vision of true impacts achieved with a new collaborative working model including efficient knowledge transfer and a shared clear scientific focus. Our consortium is particularly well balanced, focussed and well resourced to cover the value chain from discovery research to applications utilising novel intersectoral collaborations to expedite the utilisation process.

Appel à propositions

Voir d’autres projets de cet appel


Contribution de l’UE
€ 946 883,00
9 Dublin

Voir sur la carte

Ireland Eastern and Midland Dublin
Type d’activité
Higher or Secondary Education Establishments
Contact administratif
Dermot Diamond (Prof.)
Coût total
Aucune donnée

Participants (5)